Peptide-Functionalized Nanoinhibitor Restrains Brain Tumor Growth by Abrogating Mesenchymal-Epithelial Transition Factor (MET) Signaling

Malignant gliomas are the most common primary brain tumors and are associated with aggressive growth, high morbidity, and mortality. Aberrant mesenchymal-epithelial transition factor (MET) activation occurs in approximately 30% of glioma patients and correlates with poor prognosis, elevated invasion...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nano letters 2018-09, Vol.18 (9), p.5488-5498
Hauptverfasser:	Wu, Yingwei, Fan, Qi, Zeng, Feng, Zhu, Jinyu, Chen, Jian, Fan, Dandan, Li, Xinwei, Duan, Wenjia, Guo, Qinghua, Cao, Zhonglian, Briley-Saebo, Karen, Li, Cong, Tao, Xiaofeng
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!